OncoSwift® Endometrial Comprehensive
Unique Identifier:
ML-L005
Name on Requisition:
OncoSwift® Endometrial Comprehensive
Product Line:
LB
Panel Group:
Liquid Biopsy Panels
Panel Name:
OncoSwift® Endometrial Comprehensive
Methodology
Molecular
NGS
Test Description and clinical significance
Genes
AKT1, APC, ARID1A, ARID2, ATM, BRAF, BRCA1, BRCA2, CDK12, CDK4, CHEK2, CTNNB1, EPCAM, ERBB2, ESR1, FBXW7, KRAS, MDM2, MLH1, MSH2, MSH6, NBN, NRAS, NTRK1, NTRK2, NTRK3, PALB2, PIK3CA, PMS2, POLE, POLD1, PPP2R1A, PTEN, RET, RNF43, SAMD4, STK11, TP53
Disease:
endometrial carcinoma
The OncoSwift® Endometrial Comprehensive Panel evaluates the genetic profile of endometrial carcinomas, detecting mutations, fusions, and MSI status to define molecular subtypes. Results provide diagnostic and prognostic insights and guide targeted and immunotherapy selection.
Specimen Requirements
Preparation:
PB
Collection:
Two tubes of peripheral blood (10mL/tube) are collected in PAXgene Blood ccfDNA tube
Stability:
7 to 10 days at room temperature
Unacceptable Conditions:
Specimen submitted is not in the PAXgene Blood ccfDNA Tubes or n the PAXgene Blood ccfDNA tube after expired date. Insufficient specimen (less than 10 mL whole blood/tube). Specimen is leaking from the collection tube, or the glass tube is broken. Gross hemolysis. Bacterial overgrowth
Submitted with incomplete requisition form (unless a requisition is subsequently sent). Unlabeled or improperly labeled specimens, without contact information or when failing to reach the ordering physician for clarification. cfDNA shipped in inappropriate temperature .
Storage & Transport
7 to 10 days at room temperature
CPT(s)
81464
New York Approved
Yes
TAT
7
Requisition Type
LB
Levels of Service
Full
DexS Code
Z05CA
Prefix
MI
*The CPT codes provided are for informational purposes only and are based on AMA guidelines The billing party is solely responsible for correct CPT coding.
